Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond

In the era of escalating antimicrobial resistance, the need for antibacterial drugs with novel or improved modes of action (MOAs) is a health concern of utmost importance. Adding or improving the chelating abilities of existing drugs or finding new, nature-inspired chelating agents seems to be one o...

Descripción completa

Detalles Bibliográficos
Autores principales: Repac Antić, Davorka, Parčina, Marijo, Gobin, Ivana, Petković Didović, Mirna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405089/
https://www.ncbi.nlm.nih.gov/pubmed/36009974
http://dx.doi.org/10.3390/antibiotics11081105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405089/
https://www.ncbi.nlm.nih.gov/pubmed/36009974
http://dx.doi.org/10.3390/antibiotics11081105

Ejemplares similares